Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: Single-point and longitudinal assessments

Journal of Neuroimmunology

Volumn 264, Issue 1-2, 2013, Pages 106-113

  Morris Berry, C M ^a   Pollard, M ^a   Gao, S ^a   Thompson, C ^b   Singer, H S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Anti neuronal antibodies; D2 receptor; PANDAS; Single point and longitudinal; Tourette syndrome; Tubulin

Indexed keywords

ANTISTREPTOLYSIN; BACTERIUM ANTIBODY; DEOXYRIBONUCLEASE B ANTIBODY; DOPAMINE 2 RECEPTOR; N ACETYL BETA DEXTRO GLUCOSAMINE; N ACETYLGLUCOSAMINE; TUBULIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH A STREPTOCOCCAL INFECTION; PRIORITY JOURNAL; SCHOOL CHILD; STREPTOCOCCUS INFECTION;

ANTI-NEURONAL ANTIBODIES; D2 RECEPTOR; PANDAS; SINGLE-POINT AND LONGITUDINAL; TOURETTE SYNDROME; TUBULIN;

ADOLESCENT; ANTIBODIES; BACTERIAL PROTEINS; CHILD; DEOXYRIBONUCLEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; POLYENDOCRINOPATHIES, AUTOIMMUNE; RECEPTORS, DOPAMINE D2; STREPTOLYSINS; TOURETTE SYNDROME; TUBULIN;

EID: 84886786029     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.09.010     Document Type: Article

References (41)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Author, Washington, DC, (text rev.). 4th ed.
2. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., Harley J.B. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 2003, 349:1526-1533.
3. Ben-Pazi H., Stoner J.A., Cunningham M.W. Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea. PLoS One 2013, (in press).
4. Brilot F., Merheb V., Ding A., Murphy T., Dale R.C. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 2011, 76:1508-1513.
5. Brimberg L., Benhar I., Mascaro-Blanco A., Alvarez K., Lotan D., Winter C., Klein J., Moses A.E., Somnier F.E., Leckman J.F., Swedo S.E., Cunningham M.W., Joel D. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 2012, 37:2076-2087.
6. Cardona F., Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J. Pediatr. 2001, 138:71-75.
7. Church A.J., Dale R.C., Lees A.J., Giovannoni G., Robertson M.M. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J. Neurol. Neurosurg. Psychiatry 2003, 74:602-607.
8. Dale R.C., Candler P.M., Church A.J., Wait R., Pocock J.M., Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J. Neuroimmunol. 2006, 172:187-197.
9. Dale R.C., Church A.J., Candler P.M., Chapman M., Martino D., Giovannoni G. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2006, 66:1612. (author reply 1612).
10. Dale R.C., Merheb V., Pillai S., Wang D., Cantrill L., Murphy T.K., Ben-Pazi H., Varadkar S., Aumann T.D., Horne M.K., Church A.J., Fath T., Brilot F. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012, 135:3453-3468.
11. Gause C., Morris C., Vernekar S., Pardo-Villamizar C., Grados M.A., Singer H.S. Antineuronal antibodies in OCD: comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J. Neuroimmunol. 2009, 214:118-124.
12. Johnson D.R., Kaplan E.L., Smramek J. Laboratory Diagnosis of Group A Streptococcal Infections 1998, World Health Organization, Geneva, Switzerland.
13. Johnson D.R., Kurlan R., Leckman J., Kaplan E.L. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin. Infect. Dis. 2010, 50:481-490.
14. Kawikova I., Leckman J.F., Kronig H., Katsovich L., Bessen D.E., Ghebremichael M., Bothwell A.L. Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol. Psychiatry 2007, 61:273-278.
15. Kirvan C.A., Swedo S.E., Heuser J.S., Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 2003, 9:914-920.
16. Kirvan C.A., Swedo S.E., Kurahara D., Cunningham M.W. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity 2006, 39:21-29.
17. Kirvan C.A., Swedo S.E., Snider L.A., Cunningham M.W. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J. Neuroimmunol. 2006, 179:173-179.
18. Kirvan C.A., Cox C.J., Swedo S.E., Cunningham M.W. Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J. Immunol. 2007, 178:7412-7421.
19. Kurlan R., Kaplan E.L. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 2004, 113:883-886.
20. Kurlan R., Johnson D., Kaplan E.L. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 2008, 121:1188-1197.
21. Leckman J.F., Katsovich L., Kawikova I., Lin H., Zhang H., Kronig H., Morshed S., Parveen S., Grantz H., Lombroso P.J., King R.A. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol. Psychiatry 2005, 57:667-673.
22. Leckman J.F., King R.A., Gilbert D.L., Coffey B.J., Singer H.S., Dure L.S.t, Grantz H., Katsovich L., Lin H., Lombroso P.J., Kawikova I., Johnson D.R., Kurlan R.M., Kaplan E.L. Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. J. Am. Acad. Child Adolesc. Psychiatry 2011, 50:108-118. (e103).
23. Lin H., Williams K.A., Katsovich L., Findley D.B., Grantz H., Lombroso P.J., King R.A., Bessen D.E., Johnson D., Kaplan E.L., Landeros-Weisenberger A., Zhang H., Leckman J.F. Streptococcal upper respiratory tract infections and psychosocial stress predict future tic and obsessive-compulsive symptom severity in children and adolescents with Tourette syndrome and obsessive-compulsive disorder. Biol. Psychiatry 2010, 67:684-691.
24. Lopez P.H., Schnaar R.L. Determination of glycolipid-protein interaction specificity. Methods Enzymol. 2006, 417:205-220.
25. Luo F., Leckman J.F., Katsovich L., Findley D., Grantz H., Tucker D.M., Lombroso P.J., King R.A., Bessen D.E. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 2004, 113:e578-e585.
26. Martino D., Dale R.C., Gilbert D.L., Giovannoni G., Leckman J.F. Immunopathogenic mechanisms in Tourette syndrome: a critical review. Mov. Disord. 2009, 24:1267-1279.
27. Mejia N.I., Jankovic J. Secondary tics and tourettism. Rev. Bras. Psiquiatr. 2005, 27:11-17.
28. Milton F. A correction: the use of ranks to avoid the assumption of normality implicit in the analysis of variance. J. Am. Stat. Assoc. 1939, 34:109.
29. Moller J.C., Tackenberg B., Heinzel-Gutenbrunner M., Burmester R., Oertel W.H., Bandmann O., Muller-Vahl K.R. Immunophenotyping in Tourette syndrome-a pilot study. Eur. J. Neurol. 2008, 15:749-753.
30. Morris C.M., Pardo-Villamizar C., Gause C.D., Singer H.S. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J. Neurol. Sci. 2009, 276:45-48.
31. Muller N., Riedel M., Straube A., Gunther W., Wilske B. Increased anti-streptococcal antibodies in patients with Tourette's syndrome. Psychiatry Res. 2000, 94:43-49.
32. Pavone P., Bianchini R., Parano E., Incorpora G., Rizzo R., Mazzone L., Trifiletti R.R. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr. Neurol. 2004, 30:107-110.
33. Rizzo R., Gulisano M., Pavone P., Fogliani F., Robertson M.M. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J. Child Neurol. 2006, 21:747-753.
34. Scharf J.M., Yu D., Mathews C.A., Neale B.M., Stewart S.E., Fagerness J.A., Evans P., Gamazon E., Edlund C.K., Service S.K., Tikhomirov A., Osiecki L., Illmann C., Pluzhnikov A., Konkashbaev A., Davis L.K., Han B., Crane J., Moorjani P., Crenshaw A.T., Parkin M.A., Reus V.I., Lowe T.L., Rangel-Lugo M., Chouinard S., Dion Y., Girard S., Cath D.C., Smit J.H., King R.A., Fernandez T.V., Leckman J.F., Kidd K.K., Kidd J.R., Pakstis A.J., State M.W., Herrera L.D., Romero R., Fournier E., Sandor P., Barr C.L., Phan N., Gross-Tsur V., Benarroch F., Pollak Y., Budman C.L., Bruun R.D., Erenberg G., Naarden A.L., Lee P.C., Weiss N., Kremeyer B., Berrio G.B., Campbell D.D., Cardona Silgado J.C., Ochoa W.C., Mesa Restrepo S.C., Muller H., Valencia Duarte A.V., Lyon G.J., Leppert M., Morgan J., Weiss R., Grados M.A., Anderson K., Davarya S., Singer H., Walkup J., Jankovic J., Tischfield J.A., Heiman G.A., Gilbert D.L., Hoekstra P.J., Robertson M.M., Kurlan R., Liu C., Gibbs J.R., Singleton A., Hardy J., Strengman E., Ophoff R.A., Wagner M., Moessner R., Mirel D.B., Posthuma D., Sabatti C., Eskin E., Conti D.V., Knowles J.A., Ruiz-Linares A., Rouleau G.A., Purcell S., Heutink P., Oostra B.A., McMahon W.M., Freimer N.B., Cox N.J., Pauls D.L. Genome-wide association study of Tourette's syndrome. Mol. Psychiatry 2013, 18:721-728.
35. Singer H.S. Tourette's syndrome: from behaviour to biology. Lancet Neurol. 2005, 4:149-159.
36. Singer H.S., Hong J.J., Yoon D.Y., Williams P.N. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005, 65:1701-1707.
37. Singer H.S., Gause C., Morris C., Lopez P. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 2008, 121:1198-1205.
38. Singer H.S., Gilbert D.L., Wolf D.S., Mink J.W., Kurlan R. Moving from PANDAS to CANS. J. Pediatr. 2012, 160:725-731.
39. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., Lougee L., Dow S., Zamkoff J., Dubbert B.K. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry 1998, 155:264-271.
40. Swedo S.E., Leonard H.L., Rapoport J.L. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics 2004, 113:907-911.
41. Yeh C.B., Wu C.H., Tsung H.C., Chen C.W., Shyu J.F., Leckman J.F. Antineural antibody in patients with Tourette's syndrome and their family members. J. Biomed. Sci. 2006, 13:101-112.